01 1Zhejiang Ausun Pharmaceutical
01 1LUBIPROSTONE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-10-06
Pay. Date : 2016-08-16
DMF Number : 30802
Submission : 2016-08-08
Status : Active
Type : II
20
Zhejiang Ausun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Accelerating Development of APIs & Chemical Intermediates through innovation.
One of their notable products is LUBIPROSTONE, with a corresponding US DMF Number 30802.
Remarkably, this DMF maintains an Active status since its submission on August 08, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 06, 2016, and payment made on August 16, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
